Navigation Links
Galiximab in combination with rituximab in patients with previously untreated follicular lymphoma
Date:6/7/2008

Lugano, Switzerland June 7, 2008 The Cancer and Leukemia Group B (CALGB) today announced data from a phase II clinical trial showing that 70 percent of patients with previously untreated follicular lymphoma responded to treatment with galiximab, an investigational anti-CD80 monoclonal antibody, when given in combination with rituximab. Of the 61 patients in the study, 44 percent achieved a complete response and 26 percent had a partial response. The data were presented at the 10th International Conference on Malignant Lymphoma (ICML).

The results of this open label study suggest that adding galiximab to rituximab may be a promising regimen for patients with follicular lymphoma (FL), a common type of non-Hodgkin lymphoma (NHL), and that further study is warranted. The objective of the CALGB-coordinated study is to determine the overall response rate (ORR) and time-to-progression of the disease after treatment with a combined regimen of galiximab and rituximab. At this point, however, it is too early to assess the time-to-progression endpoint.

"Most non-Hodgkin lymphoma patients receive rituximab, either as a single agent or in combination with chemotherapy," said Myron Czuczman, M.D., Roswell Park Cancer Institute, principal investigator of this study. "Now, 'biologic' agents are being studied in combination to assess the efficacy of dual antibody therapies as potential alternatives to chemotherapy-based regimens."

Patients enrolled in the study had been diagnosed with CD20-positive FL but had not received treatment for the disease. Study patients were given galiximab plus rituximab together once a week for four weeks and then every two months for the next eight months. This "extended induction" schedule was chosen based on results from an earlier Swiss (SAKK) trial using the same schedule with single-agent rituximab. Thirteen percent of patients reported a grade 3 adverse event; no grade 4 toxicities were associated with this combi
'/>"/>

Contact: Rachi Govil
rachi.govil@offspringpr.com
212-798-9827
Offspring PR
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Human RecQ helicases, homologous recombination and genomic instability
2. Abnormal fat metabolism underlies heart problems in diabetic patients
3. A new radiation therapy treatment developed for head and neck cancer patients
4. Device helps patients survive, regain function til transplant
5. Diet support helps chronic kidney patients
6. Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials
7. Doctors learn to control their own brains pain responses to better treat patients
8. Jefferson urologists studying regenerated neo-bladder to help spinal cord injury patients
9. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
10. New class of drug offers hope to treatment-resistant AIDS patients
11. Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ntists have crystallised a protein that may help g...e protein could be used by probiotic producers to ...efit to people. , "Probiotics need to interact wi...t, and if they attach to surfaces in the gut they ...rt their activity," says Dr Nathalie Juge from the...
(Date:11/24/2009)...TON ROUGE Antarctica has long held secrets of the...il recently, there has been very little informatio...h miles of ice for millions of years. Now, a team ...SU have been funded to the tune of $10 million do...to get to the bottom of things literally. These s...
(Date:11/23/2009)...ington, D.C. The community-associated strain of t...ia resistant to most common antibioticsposes a far...s making its way into hospitals, according to a st...Diseases . , The new threat is easily picked up...ces and has increased the overall burden of MRSA w...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Memorial University Medical Center 28MUMC 29 Implements PNA FISH 28R 29 Tests to Help Provide Best Care for Patients with Bloodstream Infections 47607 1Memorial University Medical Center 28MUMC 29 Implements PNA FISH 28R 29 Tests to Help Provide Best Care for Patients with Bloodstream Infections 47607 2Memorial University Medical Center 28MUMC 29 Implements PNA FISH 28R 29 Tests to Help Provide Best Care for Patients with Bloodstream Infections 47607 3Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 47605 1Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 47605 2Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 47605 3Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 47605 4Clinical Utility of Exhaled Nitric Oxide Highlighted By American Thoracic Society Panel 47603 1Clinical Utility of Exhaled Nitric Oxide Highlighted By American Thoracic Society Panel 47603 2
...eral papers related to analyses of the amphioxus (...phioxus, or lancelet, is a cephalochordate residin...s, bearing resemblance to a small fish, however la... the chordata phylum along with tunicates (sea squ...e or spinal column characteristic of vertebrate an...
...creature led by scientists at Scripps Institution ...ght on a key area of the tree of life. , Linda Ho...y, and her colleagues from the United States, Euro...tal elements of the genetic makeup of a small, wo... as a lancelet. , Amphioxus is not widely known t...
...ecognized gene that places one at risk for Alzheim...and whites, according to new research led by Flori...atalie Sachs-Ericsson and graduate student Kathryn...lele is a risk factor for African-Americans as wel...elief that the gene is only a risk factor for whit...
Other Biology News:Genome sequence of small marine creature sheds light on vertebrate origins 2Genome sequence of small marine creature sheds light on vertebrate origins 3Worm-like marine animal providing 2Worm-like marine animal providing 3Known genetic risk for Alzheimer's in whites also places blacks at risk 2
(Date:11/24/2009)...TTLE, Nov. 24 Blue Marble Energy C...sa Public Development Authority (OPDA) were recent...ity Economic Revitalization Board (CERB) in a priv...rst specialty biochemical biorefinery in Lincoln C...ntly speed the development of our biorefinery and ...
(Date:11/24/2009)...X VENTURE: HTL , TORONTO, Nov. 24 /PRNewswire...ormerly Calotto Capital Inc., a leading provider o...tem cell research and fertility clinic markets, to... the third quarter ended September 30, 2009. , , ...illion compared with $1.43 million in Q3 2008, ...
(Date:11/24/2009)...EDWOOD CITY, Calif., Nov. 24 /PRNewswire-FirstCall...nnounced that Randy Scott, Genomic Health,s Execut...r Jaffray Health Care Conference in New York City ..., To access the live and subsequently archived w...ations section of Genomic Health,s website at htt...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the g... China,s patent office is now the world,s leading ...stry. China trailed Japan,s patent office, the Wor...the United States Patent and Trademark Office (USP...n 2005, WIPO in 2006, and exceeded Japan for the f...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...-3 phospholipids in NKO(R) outperform established,...3 formulations -, - Study results used to di... program -, , , LAVAL, ...ologies & Bioressources Inc. ("Neptune") (NASD...ve results from a human clinical trial conducted i...
.... 19 Jazz Pharmaceuticals,Inc. (Nasdaq: JAZZ ) ...entation,planned for today at the Lazard Capital M... proximity of the release of preliminary top-line ...al of JZP-6 (sodium oxybate) for,the treatment of ... it will release the preliminary top-line data,wit...
...wswire-FirstCall/ - GeneNews Limited (TSX: GEN), a...er tests for the early detection of diseases and p... formation of a Canadian Colorectal Cancer Advisor...heed JeeJeebhoy, Andy Smith and Mr. Barry Stein wi...n strategies for the Canadian commercialization of...
Other Biology Technology:Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile 2Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile 3Human clinical study demonstrates superior Neptune Krill Oil NKO(R) pharmacokinetic profile 4GeneNews appoints Canadian Colorectal Cancer Advisory Board 2GeneNews appoints Canadian Colorectal Cancer Advisory Board 3
Anti-rat Ig HRP detection kit from BD Biosciences Pharmingen
Agarose, high gelling temperature, Molecular Biology Grade from Research Organics, Inc.
Rabbit Anti-Human Q96IR3 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Agarose, high EEO, Molecular Biology Grade from Research Organics, Inc.
Biology Products: